These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 12231392)

  • 21. Protective effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced acute kidney injury in a rat model of sepsis.
    Liu L; Song Y; Zhao M; Yi Z; Zeng Q
    Int Urol Nephrol; 2015 Oct; 47(10):1745-52. PubMed ID: 26300162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney.
    Iguchi T; Nishikawa M; Chang B; Muroya O; Sato EF; Nakatani T; Inoue M
    Free Radic Res; 2004 Apr; 38(4):333-41. PubMed ID: 15190930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.
    Doi K; Suzuki Y; Nakao A; Fujita T; Noiri E
    Kidney Int; 2004 May; 65(5):1714-23. PubMed ID: 15086910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Bezerra CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):145-55. PubMed ID: 17396264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion.
    Chiazza F; Chegaev K; Rogazzo M; Cutrin JC; Benetti E; Lazzarato L; Fruttero R; Collino M
    Oxid Med Cell Longev; 2015; 2015():804659. PubMed ID: 25834700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats.
    Sueishi K; Mishima K; Makino K; Itoh Y; Tsuruya K; Hirakata H; Oishi R
    Eur J Pharmacol; 2002 Sep; 451(2):203-8. PubMed ID: 12231392
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.